|
XAIR | Beyond Air, Inc. |
|
|
XAIR | Beyond Air, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 1.31 |
| Leverage | 46.17% |
| Market Cap | $ 14.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -52.1m |
| Margin | -2175.48% |
Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems. The company is headquartered in Garden City, New York.